[Re-treatment guideline of ranibizumab (genetical recombination) in the maintenance phase].
Tano
Yasuo
Y
Department of Ophthalmology, Shiga University of Medical Science, Japan.
Ohji
Masahito
M
Ishibashi
Tatsuro
T
Shiraga
Fumio
F
Tokoro
Takashi
T
Yuzawa
Mitsuko
M
Yoshimura
Nagahisa
N
D000465:Algorithms; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D000069579:Ranibizumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab